New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
TELA Bio, Inc.
TELA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

103M

Medical - Devices

Next Earning date - 20 Mar 2025

103M

Medical - Devices

Next Earning date - 20 Mar 2025

2.61USD

Shape0.01 ( 0.38%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-84%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated February 17, 2025
1W 0.00 % 1M -0.76 % 3M -9.38 % 1Y -63.03 %

Key Metrics

Shape
  • Market Cap

    102.80M


  • Shares Outstanding

    39.39M


  • Share in Float

    30.77M


  • Dividende

    0


  • Earning Date

    20 Mar 2025


  • Price Target

    2.61


  • Average Volume

    164745


  • Beta

    0.999


  • Range

    2.3-7.29


  • Industry

    Medical - Devices


  • Website

    https://www.telabio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TELA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$94M

Shape395%

2025-Revenue

$0.61

Shape-46%

2025-EPS

$87M

Shape-891%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.52
vs -0.59

Q1.23

arrow
arrow

N/A

-0.63
vs -0.75

Q2.23

arrow
arrow

N/A

-0.46
vs -0.80

Q3.23

arrow
arrow

N/A

-0.45
vs -0.64

Q4.23

arrow
arrow

N/A

-0.53
vs -0.52

Q1.24

arrow
arrow

N/A

-0.23
vs -0.63

Q2.24

arrow
arrow

N/A

-0.51
vs -0.46

Q3.24

arrow
arrow

N/A

-0.42
vs -0.45

Q4.24

arrow
arrow

N/A

-0.21
vs -0.53

Q1.25

arrow
arrow

N/A

-0.20
vs -0.23

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+39%

11.6M  vs 8.4M

Q1.23

arrow
arrow

+45%

11.9M  vs 8.2M

Q2.23

arrow
arrow

+39%

14.5M  vs 10.4M

Q3.23

arrow
arrow

+35%

15.1M  vs 11.2M

Q4.23

arrow
arrow

+46%

17M  vs 11.6M

Q1.24

arrow
arrow

+39%

16.6M  vs 11.9M

Q2.24

arrow
arrow

+11%

16.1M  vs 14.5M

Q3.24

arrow
arrow

+26%

19M  vs 15.1M

Q4.24

arrow
arrow

+36%

23.2M  vs 17M

Q1.25

arrow
arrow

+27%

21M  vs 16.6M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-68%

-0.68
vs -0.51

Q1.23

arrow
arrow

-447%

-4.47
vs -0.68

Q2.23

arrow
arrow

-27%

-0.27
vs -4.47

Q3.23

arrow
arrow

-36%

-0.36
vs -0.27

Q4.23

arrow
arrow

-68%

-0.68
vs -0.36

Q1.24

arrow
arrow

-39%

-0.39
vs -0.68

Q2.24

arrow
arrow

-439%

-4.39
vs -0.39

Q3.24

arrow
arrow

+165%

1.65
vs -4.39

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

56

56
vs 49

14%

Q2.23

arrow
arrow

68

68
vs 56

21%

Q3.23

arrow
arrow

67

67
vs 68

-1%

Q4.23

arrow
arrow

58

58
vs 67

-13%

Q1.24

arrow
arrow

60

60
vs 58

3%

Q2.24

arrow
arrow

70

70
vs 60

17%

Q3.24

arrow
arrow

51

51
vs 70

-27%

Q4.24

arrow
arrow

21

21
vs 51

-59%

Earnings Growth

Latest News